Clinical Trials Directory

Trials / Conditions / Relapsed Acute Lymphoblastic Leukemia

Relapsed Acute Lymphoblastic Leukemia

7 registered clinical trials studyying Relapsed Acute Lymphoblastic Leukemia.

StatusTrialSponsorPhase
Active Not RecruitingTrial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
NCT05192889
St. Jude Children's Research HospitalPhase 1 / Phase 2
CompletedPalbociclib in Combo w/Chemotherapy in Peds Relapsed/Refractory Acute Lymphoblastic Leukemia
NCT04996160
Tanja Andrea GruberPhase 1
UnknownStudy Evaluating the Efficacy and Safety With CD19CAR-T for Relapsed or Refractory Acute Lymphoblastic Leukemi
NCT04012879
Chinese PLA General HospitalPhase 1
CompletedPevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic
NCT03349281
Julio Barredo, MDPhase 1
CompletedVyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia
NCT03575325
H. Lee Moffitt Cancer Center and Research InstitutePhase 2
TerminatedPhase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
NCT01743807
Therapeutic Advances in Childhood Leukemia ConsortiumPhase 1
TerminatedErwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224)
NCT00928200
Therapeutic Advances in Childhood Leukemia ConsortiumPhase 1